Cargando…
Tissue transglutaminase treatment leads to concentration-dependent changes in dendritic cell phenotype - implications for the role of transglutaminase in coeliac disease
Dendritic cells (DCs) are part of the innate immune system with a key role in initiating and modulating T cell mediated immune responses. Coeliac disease is caused by inappropriate activation of such a response leading to small intestinal inflammation when gluten is ingested. Tissue transglutaminase...
Autores principales: | Dalleywater, William J, Chau, David YS, Ghaemmaghami, Amir M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3352302/ https://www.ncbi.nlm.nih.gov/pubmed/22507564 http://dx.doi.org/10.1186/1471-2172-13-20 |
Ejemplares similares
-
Expression of transglutaminase 2 in human gut epithelial cells: Implications for coeliac disease
por: Amundsen, Sunniva F., et al.
Publicado: (2023) -
Clinical Utility of Anti-Tissue Transglutaminase Antibodies for Diagnosis and Monitoring of Coeliac Disease in Children and Adolescents
por: Szaflarska-Poplawska, Anna, et al.
Publicado: (2004) -
T Cell Response Toward Tissue-and Epidermal-Transglutaminases in Coeliac Disease Patients Developing Dermatitis Herpetiformis
por: Caproni, Marzia, et al.
Publicado: (2021) -
Tissue Transglutaminase but Not Microbial Transglutaminase Is Inhibited by Exogenous Oxidative Substances in Celiac Disease
por: Stricker, Sebastian, et al.
Publicado: (2022) -
Type 2 Transglutaminase in Coeliac Disease: A Key Player in Pathogenesis, Diagnosis and Therapy
por: Paolella, Gaetana, et al.
Publicado: (2022)